Log in or Sign up for Free to view tailored content for your specialty!
Rheumatoid Arthritis News
HHS awards up to $31M for potential OA therapy; Congress funds veteran arthritis research
A pair of research initiatives for arthritis and osteoarthritis are receiving tens of millions of dollars from the U.S. government.
Patients with prior sinusitis have greater rheumatic disease risk
Patients with prior sinusitis demonstrate an increased risk for many rheumatic diseases, including antiphospholipid syndrome, Sjögren’s disease and seronegative rheumatoid arthritis, according to data published in RMD Open.
Log in or Sign up for Free to view tailored content for your specialty!
Source of surging autoimmunity may lie in ‘a thousand cuts’
The common consensus for some time has been that the prevalence of autoimmunity and autoimmune diseases has been on the rise.
Q&A: Rheumatologists encouraged to address gender disparities in RA
Although it is still unclear why gender differences exist in rheumatoid arthritis, it is known that the disease is more prevalent among and tends to be more painful for women.
Partners in precision: PrismRA now available via ‘thousands’ of Quest collection sites
Precision medicine in rheumatoid arthritis expanded in a small but key measure late last year, when Quest Diagnostics and Scipher Medicine announced a partnership to provide RNA extraction and sequencing services for the latter’s PrismRA test.
Cardiovascular comorbidity risk highest near time of rheumatic disease diagnosis
Among patients with rheumatic diseases, the risk for cardiovascular comorbidity is highest during the period immediately before or after initial diagnosis, according to data published in Seminars in Arthritis and Rheumatism.
Increased cereal fiber intake may reduce rheumatoid arthritis risk
Individuals with higher cereal fiber intake are less likely to develop rheumatoid arthritis, according to data published in Nature Scientific Reports.
New legislation may tame ‘wild west’ of cannabis research in rheumatology
A law allowing for medical cannabis research could have far-reaching implications in rheumatology and across the health care spectrum, but there are still significant hurdles to clear before cannabinoids become part of routine care.
FDA approves second tocilizumab biosimilar; first available in IV, subcutaneous forms
The FDA has approved Tyenne, the second tocilizumab biosimilar overall and the first available in both intravenous and subcutaneous formulations, according to a press release from its manufacturer.
IMIDs not tied to adverse pregnancy outcomes overall; lupus, APS linked to preterm birth
Pregnant patients with lupus or antiphospholipid syndrome have a higher risk for preterm birth, although immune-mediated inflammatory diseases in general are “only weakly associated” with adverse pregnancy outcomes, according to data.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read